OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial by Francis D, Tartaglia J, Rerks-Ngam S, Dally L, Nitayaphan S, Ratto-Kim S, Jongrakthaitae S, Phuang-ngem Y, Chuenarom W, Schuetz A, Trichavaroj R, de Souza MS, Michael NL, Paris RM, Kim JH

Expression of protein complexes using multiple Escherichia coli protein co-expression systems: a benchmarking study. by Busso, D, Peleg, Y, Heidebrecht, T, Romier, C, Jacobovitch, Y, Dantes, A, Salim, L, Troesch, E, Schuetz, A, Heinemann, U, Folkers, G, Geerlof, A, Wilmanns, M, Polewacz, A, Quedenau, C, Büssow, K, Adamson, R, Blagova, E, Walton, J, Cartwright, J, Bird, L, Owens, R, Berrow, N, Wilson, K, Sussman, J

Expression of protein complexes using multiple Escherichia coli protein co-expression systems: A benchmarking study by Busso, D, Peleg, Y, Heidebrecht, T, Romier, C, Jacobovitch, Y, Dantes, A, Salim, L, Troesch, E, Schuetz, A, Heinemann, U, Folkers, G, Geerlof, A, Wilmanns, M, Polewacz, A, Quedenau, C, Büssow, K, Adamson, R, Blagova, E, Walton, J, Cartwright, J, Bird, L, Owens, R, Berrow, N, Wilson, K, Sussman, J